Terms: = Uterine cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306
25 results:
1. Comparison of functional and oncological outcomes between uterus-sparing radical cystectomy and standard radical cystectomy in females: A retrospective study.
Park JS; Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
Investig Clin Urol; 2022 Nov; 63(6):612-622. PubMed ID: 36347550
[TBL] [Abstract] [Full Text] [Related]
2. Recruitment strategies to promote uptake of cervical cancer screening in the West Region of Cameroon.
Pham MA; Benkortbi K; Kenfack B; Tincho Foguem E; Sormani J; Wisniak A; Lemoupa Makajio S; Manga E; Vassilakos P; Petignat P
BMC Public Health; 2022 Mar; 22(1):548. PubMed ID: 35305588
[TBL] [Abstract] [Full Text] [Related]
3. Primary Synovial Sarcoma of the uterine Cervix: First Case Report.
Vaziri Fard E; Zhang S; El Achi HS; Covinsky M
Int J Gynecol Pathol; 2021 Mar; 40(2):196-203. PubMed ID: 33075021
[TBL] [Abstract] [Full Text] [Related]
4. Long-term evaluation of renal function and neurogenic bladder following radical hysterectomy in patients with uterine cervical cancer.
Komatsu H; Oishi T; Osaku D; Kudoh A; Shimogai R; Chikumi J; Sato S; Harada T
J Obstet Gynaecol Res; 2020 Oct; 46(10):2108-2114. PubMed ID: 32686280
[TBL] [Abstract] [Full Text] [Related]
5. cancer initiating-cells are enriched in the CA9 positive fraction of primary cervix cancer xenografts.
Marie-Egyptienne DT; Chaudary N; Kalliomäki T; Hedley DW; Hill RP
Oncotarget; 2017 Jan; 8(1):1392-1404. PubMed ID: 27901496
[TBL] [Abstract] [Full Text] [Related]
6. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
Asano T; Hirohashi Y; Torigoe T; Mariya T; Horibe R; Kuroda T; Tabuchi Y; Saijo H; Yasuda K; Mizuuchi M; Takahashi A; Asanuma H; Hasegawa T; Saito T; Sato N
Oncotarget; 2016 Mar; 7(10):11223-37. PubMed ID: 26849232
[TBL] [Abstract] [Full Text] [Related]
7. Tumor Characteristics and Survival Outcome of Endometrial cancer Arising in Adenomyosis: An Exploratory Analysis.
Matsuo K; Moeini A; Machida H; Scannell CA; Casabar JK; Kakuda M; Adachi S; Garcia-Sayre J; Ueda Y; Roman LD
Ann Surg Oncol; 2016 Mar; 23(3):959-67. PubMed ID: 26542589
[TBL] [Abstract] [Full Text] [Related]
8. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
Karanian-Philippe M; Velasco V; Longy M; Floquet A; Arnould L; Coindre JM; Le Naoures-Méar C; Averous G; Guyon F; MacGrogan G; Croce S
Am J Surg Pathol; 2015 Sep; 39(9):1197-205. PubMed ID: 26135561
[TBL] [Abstract] [Full Text] [Related]
9. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.
Rahadiani N; Ikeda J; Mamat S; Matsuzaki S; Ueda Y; Umehara R; Tian T; Wang Y; Enomoto T; Kimura T; Aozasa K; Morii E
Cancer Sci; 2011 Apr; 102(4):903-8. PubMed ID: 21231983
[TBL] [Abstract] [Full Text] [Related]
10. [Multi-institute survey on actual conditions of urologic management for severe bladder dysfunction after hysterectomy].
Yoshimura K; Kamoto T; Okada T; Kawakita M; Ikeda H; Hayashi T; Yamamoto M; Kanamaru H; Masui K; Okuno H; Aoyama T; Terai A; Higashi S; Nishio Y; Ishitoya S; Okumura K; Nakajima M; Shichiri Y; Ueda T; Oka H; Fukuzawa S; Okamura Y; Nonomura M; Okasho K; Taki Y; Onishi H; Moroi S; Nishimura K; Ito N; Soeda A; Sasaki M; Ito M; Ogura K; Ogawa O
Hinyokika Kiyo; 2008 Jun; 54(6):401-5. PubMed ID: 18634434
[TBL] [Abstract] [Full Text] [Related]
11. Clonality analysis of synchronous lesions of cervical carcinoma based on X chromosome inactivation polymorphism, human papillomavirus type 16 genome mutations, and loss of heterozygosity.
Hu X; Pang T; Asplund A; Pontén J; Nistér M
J Exp Med; 2002 Apr; 195(7):845-54. PubMed ID: 11927629
[TBL] [Abstract] [Full Text] [Related]
12. Sequence variations of the late upstream region of HPV16 in cervical intraepithelial neoplasm and invasive carcinoma.
Pang T; Hu X; Ponten J
Int J Gynecol Cancer; 2002; 12(1):99-104. PubMed ID: 11860543
[TBL] [Abstract] [Full Text] [Related]
13. [Clean intermittent catheterization in neurogenic bladder patients with vesicoureteral reflux].
Takechi S; Nishio S; Yokoyama M; Iwata H; Takeuchi M
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1520-4. PubMed ID: 7474600
[TBL] [Abstract] [Full Text] [Related]
14. Immune reactive proteins in patients irradiated for cervical cancer. One year follow up.
Juranić Z; Vucković-Dekić L; Durbaba M
Neoplasma; 1994; 41(4):225-8. PubMed ID: 7935997
[TBL] [Abstract] [Full Text] [Related]
15. Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.
Dobryszycka W; Gerber J; Zuwała-Jagiełło J; Ujec M
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):41-50. PubMed ID: 1725104
[TBL] [Abstract] [Full Text] [Related]
16. Cervical carcinoma: a comparison of four potential biochemical tumor markers.
Dodd JK; Henry RJ; Tyler JP; Houghton CR
Gynecol Oncol; 1989 Feb; 32(2):248-52. PubMed ID: 2910788
[TBL] [Abstract] [Full Text] [Related]
17. Immune reactive proteins as prognostic and clinical markers in malignant cervical neoplasia.
Radhakrishna Pillai M; Balaram P; Hareendran NK; Bindu S; Abraham T; Padmanabhan TK; Nair MK
J Cancer Res Clin Oncol; 1989; 115(6):583-91. PubMed ID: 2606934
[TBL] [Abstract] [Full Text] [Related]
18. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients.
Das S
Arch Geschwulstforsch; 1987; 57(4):283-6. PubMed ID: 3675140
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of circulating immune complexes (C.I.C.) in endometrial cancer.
Benedetti Panici P; Di Roberto P; Scambia G; Cauda R; Laghi V; Mancuso S; Bompiani A
Eur J Gynaecol Oncol; 1986; 7(1):27-9. PubMed ID: 3699057
[TBL] [Abstract] [Full Text] [Related]
20. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
[TBL] [Abstract] [Full Text] [Related]
[Next]
